Human cancer studies have found IL-4R expression to be elevated in many tumours types such as bladder, lung, breast, liver, and prostate cancer [135, 189, 190], suggesting that IL-4-signalling can be selectively targeted therapeutically for cancer treatment. This evidence concerns the gene IL4 and cancer.